Protocol Ledger

NCT03702920 · Phase III · TERMINATED

Short-term Survival of Subjects With Acute-on-chronic Liver Failure After Plasma Exchange With Human Serum Albumin 5%

Interventional Phase III clinical trial protocol NCT03702920 sponsored by Instituto Grifols in Gastroenterology, Hepatology, and Renal, reconciled from NIH NLM ClinicalTrials.gov REST API v2.

Start Date: 2019-06-17 Enrollment: 274 participants (ACTUAL) Federal Source: clinicaltrials.gov/study/NCT03702920
Track in Studio / Generate Client Brief ->
Registered Enrollment vs Phase II/III Median (145 pts)274 participants (ACTUAL)
Disclosed U.S. Hospital Campuses vs Median (6 sites)4 sites

Reconciled ClinicalTrials.gov v2 Protocol Specification

Structured Registry Fields for NCT03702920
Protocol FieldVerified Registry Value
NCT IdentifierNCT03702920
Consolidated Lead SponsorInstituto Grifols
Therapeutic Condition CohortGastroenterology, Hepatology, and Renal
Clinical Trial PhasePhase III
Overall Recruitment StatusTERMINATED
Registered Enrollment274 participants (ACTUAL)
Registered Start Date2019-06-17
WhyStopped ClassificationSafety / Toxicity / Adverse Events

Named U.S. Hospital Clinical Research Sites

Search related sites and sponsors in the Interactive Directory, explore Gastroenterology, Hepatology, and Renal Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI